ARCHIVES

NCI Bypass Budget For FY99 Proposes Expansion of Cancer Clinical Trials System

This article is from The Cancer Letter archive.

Vol. 23 No. 46 | December 5, 1997

Download PDF Visit The Full Archive

Related Articles

Phase III Cyramza Trial Meets OS Primary Endpoint

September 26, 2014

NCAB Subcommittee Works On Drafting Quantitative Risk Assessment Policy

October 1, 1982

NCI Advisors Approve New $5 Million Program For Reagent Contracts.

July 10, 2009

White House Estimates Automatic Budget Cuts Would Take 8.2 Percent From NCI, NIH and FDA

September 21, 2012

FDA Clears Avastin-Interferon Combination In Renal Cancer; Interferon Role Undefined.

August 7, 2009

Guest Editorial: The Supreme Court Decision on the ACA and What It Can Mean to Oncology

June 29, 2012